Biostate AI Raises USD 12 Mn Series A Led by Accel
The company plans to deepen its dataset, expand collaborations in oncology, autoimmune, and cardiovascular research, and improve its predictive models for early disease detection and treatment response.
You're reading Entrepreneur India, an international franchise of Entrepreneur Media.
Biostate AI has raised USD 12 million in a Series A funding round led by Accel, with participation from Gaingels, Mana Ventures, InfoEdge Ventures, and returning investors Matter Venture Partners, Vision Plus Capital, and Catapult Ventures. Angel investors such as Dario Amodei (CEO, Anthropic), Emily Leproust (CEO, Twist Bioscience), and Mike Schnall-Levin (CTO, 10x Genomics) also backed the company.
The funds will be deployed to scale Biostate's AI-powered RNA sequencing (RNAseq) platform and to accelerate its vision of affordable, integrated precision medicine. The company plans to deepen its dataset, expand collaborations in oncology, autoimmune, and cardiovascular research, and improve its predictive models for early disease detection and treatment response.
Founded by serial entrepreneurs and former professors David Zhang (Rice University) and Ashwin Gopinath (MIT), Biostate AI was launched to tackle the limitations of conventional RNAseq and bring generative AI to molecular medicine. The company is pioneering a Netflix-style self-sustaining model—using its low-cost, high-throughput RNAseq platform to feed an ever-expanding AI dataset that can decode human disease.
"Just as ChatGPT transformed language understanding by learning from trillions of words, we're learning the molecular language of human disease from billions of RNA expressions from millions of samples," said Ashwin Gopinath, Co-founder and CTO.
Biostate AI's core technologies include patented methods like BIRT and PERD, enabling high-quality RNAseq from both fresh and archival tissues at a fraction of the traditional cost. The company's unified workflow standardises sample processing, reducing batch effects and making its datasets uniquely suited for AI training. Its proprietary tools, including the manuscript generator Quantaquill, simplify the path from sample to publishable insights.
CEO David Zhang explained, "Rather than solve diagnostics and therapeutics as siloed problems, we believe modern AI can understand and help cure every disease. Biostate takes the biggest leap yet by making the whole transcriptome affordable."
With over 10,000 samples processed across 150+ partners and agreements to handle hundreds of thousands more annually, Biostate AI is rapidly building the world's largest RNAseq dataset.
Accel's Shekhar Kirani summed it up: "Biostate is decoding the molecular signals that govern human health. They are laying the groundwork for a new era of diagnostics and therapeutics."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Entrepreneur
5 hours ago
- Entrepreneur
OpenAI CEO Sam Altman: AI Agents Are Like Junior Employees
OpenAI CEO Sam Altman says that companies are using AI agents (programs that run autonomously to perform complex tasks) as if they were junior employees. "You hear people that talk about their job now is to assign work to a bunch of [AI] agents, look at the quality, figure out how it fits together, give feedback," Altman said on Monday during the keynote conversation at the Snowflake Summit 2025, per Business Insider. "It sounds a lot like how they work with a team of still relatively junior employees." Related: JPMorgan Chase CEO Jamie Dimon Isn't Worried About AI Taking Over Jobs — Here's Why Meanwhile, a report last month from venture capital firm SignalFire found that AI has already led to a 25% decrease in entry-level hires from 2023 to 2024 at Meta, Microsoft, and Google. SignalFire's head of research, Asher Bantock, told TechCrunch that AI was to blame for the decline in entry-level tech roles, as it takes over more routine tasks typically carried out by junior employees. At consulting firm McKinsey, AI is performing tasks usually reserved for junior employees, like creating PowerPoint presentations and drafting proposals. McKinsey wrote in July 2024 that AI could replace up to 375 million jobs by 2030. OpenAI CEO Sam Altman. Photo byOther industry leaders have bold predictions about how quickly AI will take over entry-level jobs. Dario Amodei, 42, the CEO of the $61.5 billion company Anthropic, told Axios last week that AI could eliminate half of all entry-level white-collar jobs within the next one to five years, causing unemployment to rise as high as 20%. "It sounds crazy, and people just don't believe it," Amodei told Axios. Related: 'I Do Have a Fair Amount of Concern.' The CEO of $61 Billion Anthropic Says AI Will Take Over a Crucial Part of Software Engineers' Jobs Within a Year
Skift
5 hours ago
- Skift
The Leela Has Soft Debut, but Now Has IPO Cash
The Leela did everything right - the product was impeccable and the marketing was on-point. But it might have been betrayed by the intimidating "largest-in-Indian-hospitality" IPO size. The Leela's parent company Schloss Bangalore debuted on the Indian stock exchanges Monday at INR 406 ($4.74) - 7% below its IPO price. By Tuesday's close, it had only modestly recovered. The muted investor response comes despite high anticipation for the $400 Million IPO of the luxury chain – the largest in the Indian hospitality industry. Other recent travel IPOs
Skift
6 hours ago
- Skift
'Great Green Scam': IATA Chief Blames EU, Fuel Giants for Slow Climate Progress
The head of the International Air Transport Association (IATA), Willie Walsh, is blaming governments and fuel producers for stalling progress on aviation's climate goals. Speaking at an aviation meeting in India on Monday, Walsh said governments, particularly the European Union, have failed to provide the support needed to scale sustainable aviation fuel (SAF). 'From the outset we made it clear that it would be challenging and that the airlines could not do this on their own,' he said. 'Despite their enthusiasm, governments did not create a supportive policy framework to meet their 2030 interim target. The companies we need to be major SAF players like BP and Shell have cut back or delayed their investment.' According to IATA, when airlines use SAF in the EU, they have to pay compliance fees which cover the cost of blending the fuel and checking it meets the policy's requirements. 'It is an outrage that suppliers are charging airlines compliance fees that value SAF at double its market premium over conventional jet fuel. That's a billion-dollar windfall for fuel suppliers. This is the EU's great green scam.' Pressure Mounts Ahead of 2030 Aviation Climate Target IATA Directer willie walsh blamed governments and fuel producers for aviation's slow climate progress In 2021, IATA member airlines, which represent most of the global aviation sector, committed to reaching net zero carbon emissions by 2050. But with demand for flying rebounding sharply post-pandemic, progress has been slow. Governments gave airlines an interim target of reducing emissions by 5% by 2030. However, after a drop in emissions during Covid-19, airline emissions are expected to return to, or even exceed 2019 levels this year, according to Carbon Action Tracker. Walsh directed his sharpest criticism at the European Union's current policy, which requires airlines to use at least 2% SAF in their fuel mix by 2030. 'The EU mandate of 2% SAF in the jet fuel supply has succeeded in raising costs but has done nothing to improve production,' Walsh said. Fuel Producers Push Back Fuels Europe, which represents companies like BP and Shell, have rejected the aviation industry's claims. 'We reject claims from the aviation sector suggesting a lack of sustainable aviation fuel supply,' the group said in a statement. 'Our members are on track to meet their current mandate and exceed 2030 targets. Despite policy and investment challenges, European fuel producers have rapidly scaled SAF output and lowered costs.' An EU spokesperson told Skift it is helping with the transition to SAF through a range of initiatives such as its Refuel EU program and that the current targets are "realistic and feasible." "The implementation of ReFuelEU Aviation has already begun to stimulate production capacity within the EU, with SAF supply starting to outpace mandated minimum shares. This is a positive and necessary signal," the spokesperson said. The spokesperson said the EU is watching the price of SAF closely and recognizes that there continues to be "significant barriers to commercial deployment, primarily due to insufficient investment." They said there will be a dialogue on SAF later this year, with the goal of improving financing and de-risking investment. Skift's in-depth reporting on climate issues is made possible through the financial support of Intrepid Travel. This backing allows Skift to bring you high-quality journalism on one of the most important topics facing our planet today. Intrepid is not involved in any decisions made by Skift's editorial team.
